Sino-report
Home Sign in Research report Data Center Industry News Custom Research About us
Research report:                          Automotive  |  Electronics  |  Mechanical&Automation  |  New Energy  |  Medical  |  Advanced Materials  |  Building Products  |  Transportation  |  Communication  |  Chemical  |  Finance  |  IT Industry  |  Food  |  Home Appliances  |  Forestry  |  Agriculture  |  Textile  |  Culture Industry  |  Consumer goods  |  Others  |
 Home > Research report > Medical > Medical Devices > Text
Molecular Diagnostics Cancer Oncology - Global Market Size, Strategy and Forecasts - 2019 to 2023
Author:sino    Source:Sino-report    Number of clicks :     Update time:2018-11-24 09:12
A market that just keeps on growing. Molecular Diagnostics is positioned to directly benefit from the explosion in genomics knowledge
Hard copy USD$:  4000
Electronic copy(PDF) USD$:  4000
Hard and Electronic copy USD$:  4500

Report Overview:

A market that just keeps on growing. Molecular Diagnostics is positioned to directly benefit from the explosion in genomics knowledge. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations. Trends like ......

  • personalized medicine
  • pharmacogenomics
  • liquid biopsy
  • emergence of new economies with large markets
  • greater understanding of the role of genetic material in Disease and Health

Exciting technical developments especially in the area of pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

The report data is designed to be used! The unit volumes of tests performed is presented. Use our pricing scenarios or use your own. Project your market share and your price to reliably generate revenue forecasts or understand your own current market share position. Detailed Market Forecasts provide Price, Volume and Revenue Forecasts individually broken out by year for Oncology Testing.

In addition customization work, breakouts for particular segments, assistance and support is included free of charge with every report.

"Molecular Diagnostics Cancer Oncology - Global Market Size, Strategy and Forecasts - 2019 to 2023" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2018 United States Medicare Fee Payment Schedules to help understand test pricing in detail. See lists of all current FDA Approved Molecular Diagnostic Tests. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.

The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School
TABLE OF CONTENTS

Table of Contents

  • i. Molecular Diagnostics Oncology Market - Strategic Situation Analysis
  • ii. Guide for Executives, Marketing, Sales and Business Development Staff
  • iii. Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition

  • 1.1. What is Molecular Diagnostics
  • 1.2. The Diagnostics Revolution
  • 1.3. Market Definition
    • 1.3.1. Volumes
    • 1.3.2. Prices
    • 1.3.3. Revenue Market Size
  • 1.4. Methodology
    • 1.4.1. Authors
    • 1.4.2. Sources
  • 1.5. U.S. Medical Market and laboratory Testing - Perspective
    • 1.5.1. U.S. Medicare Expenditures for Laboratory Testing

2. Market Overview

  • 2.1. Market Participants
  • 2.2. Market Segments
    • 2.2.1. Traditional Market Segmentation
    • 2.2.2. Laboratory Focus and Segmentation
  • 2.3. Industry Structure
    • 2.3.1. Hospital Testing Share
    • 2.3.2. Economies of Scale
    • 2.3.3. Physician Office Lab's
    • 2.3.4. Physician's and POCT
  • 2.4. Profiles of Key MDx Companies
    • 10X Genomics
    • Abbott Laboratories
    • Adaptive Biotechnologies
    • Aethlon Medical
    • Agena Bioscience
    • Angle plc
    • Apocell
    • ARUP Laboratories
    • Beckman Coulter
    • Becton Dickinson
    • Bioarray Genetics
    • BioCartis
    • Biocept
    • Biodesix Inc.
    • BioFluidica
    • BioGenex
    • bioMérieux
    • Bio-Rad
    • Bio-Techne
    • Bristol-Myers Squibb
    • Cancer Genetics
    • Caris Molecular Diagnostics
    • CellMax Life
    • Charles River
    • Chronix Biomedical
    • Circulogene
    • Clearbridge BioMedics
    • Clinical Genomics
    • Cynvenio
    • Cytolumina Technologies Corp.
    • CytoTrack
    • Dako (Agilent)
    • Diagnologix LLC
    • Epic Sciences
    • Exosome Diagnostics
    • Fluidigm Corp
    • Fluxion Biosciences
    • Foundation Medicine
    • Freenome
    • Genomic Health
    • GenomOncology
    • GRAIL
    • Guardant Health
    • HalioDx
    • Horizon Discovery
    • HTG Molecular Diagnostics
    • iCellate
    • Illumina
    • Incell Dx
    • Inivata
    • Integrated Diagnostics
    • Invivoscribe
    • Leica Biosystems
    • Luminex
    • MDx Health
    • Merck & Co., Inc
    • MIODx
    • Molecular MD
    • MRM Proteomics Inc
    • Myriad Genetics/Myriad RBM
    • Nanostring
    • Natera
    • Neogenomics
    • New Oncology
    • Oncocyte
    • Ortho Clinical Diagnostics
    • Perkin Elmer
    • Personal Genome Diagnostics
    • Pfizer
    • Promega
    • Protagen Diagnostics
    • Qiagen
    • Quanterix
    • Rarecells SAS
    • Roche Diagnostics
    • Siemens
    • Silicon Biosystems
    • SkylineDx
    • SRI International
    • Sysmex
    • Thermo Fisher
    • Trovagene
    • Vortex Biosciences

3. Market Trends

  • 3.1. Factors Driving Growth
    • 3.1.1. New Diagnostics Create New Markets
    • 3.1.2. New Roles for Diagnostics.
    • 3.1.3. Longevity and Outcomes
    • 3.1.3. Expanding the Pharmaceutical Toolbox.
    • 3.1.4. Regulatory Retreat
  • 3.2. Factors Limiting Growth
    • 3.2.1. Falling Prices
    • 3.2.2. Lower Costs.
    • 3.2.3. Testing as a Controllable Cost.
    • 3.2.4. Wellness has a Downside
  • 3.3. Instrumentation and Automation
    • 3.3.1. Instruments Key to Market Share
    • 3.3.2. Bioinformatics Plays a Role.
  • 3.4. Diagnostic Technology Development
    • 3.4.1. Next Generation Sequencing.
    • 3.4.2. Shifting Role of Diagnostics
    • 3.4.3. Multiplexing and Foundation One
    • 3.4.4. Pharmacogenomics Technology
    • 3.4.5. Whole Genome Sequencing
    • 3.4.6. Gene Editing and Gene Therapy

4. Molecular Diagnostics Recent Developments

  • Recent Developments-Importance and How to Use This Section
    • Importance of These Developments
    • How to Use This Section
  • Guardant Health, Core Diagnostics to Offer Liquid Biopsy in India
  • Invitae Q3 Revenues More Than Double
  • Illumina to Acquire Pacific Biosciences
  • Lung Cancer Panel From PlexBio Receives CE Mark
  • Thermo Fisher Scientific Gets CE-IVD Mark for Oncomine Dx
  • Merck KGaA, ArcherDx Partner to Develop CDx for Downstream Therapeutic
  • Foundation Medicine and Merck to Develop Diagnostic Tests for Keytruda
  • Cancer Genetics and NovellusDx to Merge
  • ApoCell Expands Immuno-Oncology Biomarker Services
  • MRM Proteomics Inc and Exactis Innovation Partner
  • Agilent Companion Diagnostic Gains FDA Approval in Urothelial Carcinoma
  • Fluidigm Partners with GenomOncology to Provide Immuno-Oncology Solution
  • MolecularMD Launches Validated Tumor Mutation Burden Assay
  • Minomic Secures Key Patent in the United States and China
  • Biocartis and Wondfo Announce Joint Venture
  • Five Prime Therapeutics Announces Collaboration with Roche to Develop Companion Diagnostics
  • Biodesix Acquires Integrated Diagnostics
  • Predicine, Kintor Pharmaceuticals Partner on Clinical Trials, CDx
  • Bio-Techne to Acquire Exosome Dx for Up to $575M
  • GRAIL Announces Data on Detection of Early-Stage Lung Cancers
  • CellMax Life, IncellDx Partner to Develop Circulating Tumor Cell Tests
  • Quest to Offer Thermo Fisher's Oncomine Dx Target Test
  • Angle, Abbott Ink Deal for Use of FISH With Harvested CTCs
  • Foundation Medicine to Profile Samples for European Cancer Network
  • GRAIL Details Plans for Early Cancer Detection Trials, Products
  • Avalon GloboCare, Da An Gene Collaborate on Liquid Biopsy Diagnostics
  • OncoDNA Inks Russian Distribution Deal With Genext
  • Biocept Prices $15M Public Offering
  • UgenTec, MDxHealth Partner To Develop AI Software for Prostate Cancer Tests

5. Country Market Sizes-North America

  • 5.1. United States of America
    • 5.1.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 5.1.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 5.1.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 5.1.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 5.1.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 5.1.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 5.2. Canada
    • 5.2.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 5.2.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 5.2.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 5.2.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 5.2.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 5.2.6. All MDx Cancer Total-Volumes, Prices, Revenues

6. Country Markets-Europe

  • 6.1. France
    • 6.1.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 6.1.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 6.1.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 6.1.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 6.1.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 6.1.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 6.2. Germany
    • 6.2.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 6.2.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 6.2.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 6.2.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 6.2.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 6.2.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 6.3. United Kingdom
    • 6.3.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 6.3.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 6.3.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 6.3.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 6.3.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 6.3.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 6.4. Spain
    • 6.4.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 6.4.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 6.4.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 6.4.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 6.4.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 6.4.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 6.5. Italy
    • 6.5.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 6.5.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 6.5.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 6.5.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 6.5.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 6.5.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 6.6. Russia
    • 6.6.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 6.6.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 6.6.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 6.6.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 6.6.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 6.6.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 6.7. Remainder of Europe and Former Soviet Union
    • 6.7.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 6.7.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 6.7.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 6.7.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 6.7.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 6.7.6. All MDx Cancer Total-Volumes, Prices, Revenues

7. Country Markets-Asia Pacific

  • 7.1. China
    • 7.1.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 7.1.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 7.1.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 7.1.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 7.1.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 7.1.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 7.2. Japan
    • 7.2.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 7.2.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 7.2.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 7.2.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 7.2.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 7.2.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 7.3. South Korea
    • 7.3.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 7.3.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 7.3.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 7.3.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 7.3.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 7.3.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 7.4. India
    • 7.4.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 7.4.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 7.4.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 7.4.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 7.4.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 7.4.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 7.5. Australia
    • 7.5.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 7.5.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 7.5.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 7.5.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 7.5.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 7.5.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 7.6. Rest of Asia Pacific
    • 7.6.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 7.6.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 7.6.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 7.6.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 7.6.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 7.6.6. All MDx Cancer Total-Volumes, Prices, Revenues

8. Country Markets-Latin America, Africa & The Middle East

  • 8.1. Brazil
    • 8.1.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 8.1.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 8.1.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 8.1.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 8.1.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 8.1.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 8.2. Mexico
    • 8.2.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 8.2.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 8.2.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 8.2.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 8.2.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 8.2.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 8.3. Rest of Latin America
    • 8.3.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 8.3.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 8.3.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 8.3.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 8.3.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 8.3.6. All MDx Cancer Total-Volumes, Prices, Revenues
  • 8.4. Africa and The Middle East
    • 8.4.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 8.4.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 8.4.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 8.4.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 8.4.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 8.4.6. All MDx Cancer Total-Volumes, Prices, Revenues

9. Global Market Summary

  • 9.1. Global
    • 9.1.1. Lung Cancer Testing-Volumes, Prices, Revenues
    • 9.1.2. Breast Cancer Testing-Volumes, Prices, Revenues
    • 9.1.3. Colorectal Cancer Testing-Volumes, Prices, Revenues
    • 9.1.4. Prostate Cancer Testing-Volumes, Prices, Revenues
    • 9.1.5. Other Cancer Testing-Volumes, Prices, Revenues
    • 9.1.6. All MDx Cancer Total-Volumes, Prices, Revenues

10. Cancer Treatment and Trials

  • 10.1. FDA Cancer Drug Approvals by Year
  • 10.2. Clinical Trials Started 2010 to 2016
  • 10.3. Prevalence of Cancer Treatments-2015

Appendices

  • I. United States Medicare System: January 2018 Clinical Laboratory Fees Schedule-National Limit and Midpoint
  • II. FDA Approved Human Genetic Tests
  • III. FDA Approved Microbial Tests
  • III. FDA Approved Pharmacogenomics Tests

Table of Tables

  • Table 1: Lab Spending 2014 to 2024
  • TABLE 2: MARKET PLAYERS BY TYPE
  • Table 3: Clinical Laboratory Departments and Segments
  • Table 4: Laboratory Management Focus-Different Approaches
  • Table 5: Key Segmentation Variables Going Forward
  • Table 6: Five Factors Driving Growth
  • Table 7: Four Factors Limiting Growth
  • Table 8: Key Diagnostic Laboratory Technology Trends
  • Table 9: Next Generation Sequencing Technologies-Speed and Cost
  • Table 10: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 11: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 12: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 13: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 14: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 15: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 16: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 17: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 18: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 19: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 20: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 21: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 22: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 23: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 24: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 25: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 26: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 27: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 28: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 29: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 30: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 31: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 32: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 33: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 34: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 35: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 36: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 37: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 38: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 39: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 40: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 41: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 42: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 43: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 44: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 45: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 46: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 47: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 48: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 49: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 50: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 51: All MDx Cancer Testing - Volume, Price and Revenue Forecast
  • Table 52: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 53: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 54: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 55: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 56: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 57: All MDx Cancer - Volume Price and Revenue Forecast
  • Table 58: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 59: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 60: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 61: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 62: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 63: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 64: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 65: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 66: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 67: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 68: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 69: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 70: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 71: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 72: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 73: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 74: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 75: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 76: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 77: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 78: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 79: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 80: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 81: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 82: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 83: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 84: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 85: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 86: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 87: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 88: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 89: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 90: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 91: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 92: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 93: All MDx Cancer Testing - Volume, Price and Revenue Forecast
  • Table 94: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 95: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 96: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 97: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 98: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 99: All MDx Cancer - Volume Price and Revenue Forecast
  • Table 100: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 101: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 102: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 103: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 104: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 105: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 106: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 107: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 108: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 109: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 110: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 111: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 112: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 113: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 114: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 115: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 116: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 117: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 118: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 119: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 120: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 121: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 122: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 123: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 124: Lung Cancer Testing - Volume Price and Revenue Forecast
  • Table 125: Breast Cancer Testing - Volume Price and Revenue Forecast
  • Table 126: Colorectal Cancer Testing - Volume Price and Revenue Forecast
  • Table 127: Prostate Cancer Testing - Volume Price and Revenue Forecast
  • Table 128: Other Cancer Testing - Volume Price and Revenue Forecast
  • Table 129: All MDx Cancer Testing - Volume Price and Revenue Forecast
  • Table 130: 2018 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Clinical Lab Spending 2014 to 2024
  • Figure 2: Growth in Aging Population
  • Figure 3: Death Rates from Cancer - USA
  • Figure 4: Comparing MDx Diagnostic and Traditional Testing
  • Figure 5: FDA Cancer Drug Approvals by Year
  • Figure 6: Clinical Trials for Immunotherapy by Year
  • Figure 7: Pie Chart of Prevalence of Cancer Treatments

Order Online
Contact Us
Tel: 400-988-9999
Fax:010-82889999
Phone :+8615313587056
Email:Sale@sino-report.com
Email:Cousult@sino-report.com
Online Consultation
MSN :Sino-report@hotmail.com
MSN :Sino-report@foxmail.com
Skype: Please Please
Latest Reports
  More>>
[Medical Devices] Spinal Surgical Devices: Technologies and Global Markets
[Medical Devices] Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2018-2024)
[Medical Devices] Surgical Snare Market by Usability (Singel Use, Reusable), Application (GI Endoscopy, Laparoscopy, Ur
[Medical Devices] Lateral Flow Assay Market by Application (Clinical Testing (Pregnancy, Infectious Disease (Mosquito ,
[Medical Devices] Ultrasound Market by Technology (Diagnostic, FUS, SWL), Display (Color, B/W), Portability (Trolley, C
[Medical Devices] Molecular Diagnostics Cancer Oncology - Global Market Size, Strategy and Forecasts - 2019 to 2023
[Medical Devices] Connected Drug Injection Devices to 2024
[Medical Devices] Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchr
[Medical Devices] Global Hydrogel Dressings Market 2019-2023
[Medical Devices] Global Joint Reconstruction Market: Focus on Procedure Number, Type, and Country - Analysis and Forec
Popular reports
  More>>
Syndromic Multiplex Diagnostic Markets. Strategies and Trends. Forecasts by Syndrome (respiratory, Se
Global Surgical Sealants Market Research and Forecast 2018-2023
Global Medical Imaging Instrument Market Forecast 2018-2026
Global Fundus Cameras Market 2018-2022
Global High Throughput Screening (HTS) Market 2018-2022
Global Mammography X-ray Unit Sales Market Report 2018
Global Clinical In Vitro Diagnostic Medical Laboratory Services Market. Strategies & Trends. Volu
Medical Simulation Market - Global Scenario, Market Size, Outlook, Trend and Forecast, 2016 - 2025
Transcatheter Heart Valve Replacement Market, Patient Numbers, by Position (TMVR, TAVR), by Valve Typ
Global Electric Handpieces Market Research Report 2018
Industry Data
  More>>
China opens market to Kenya's agricultural products
China's publishing industry booming over past 40 years
Industrial Production Operation in July 2018
Total Retail Sales of Consumer Goods in July 2018
National Real Estate Development and Sales in the First Seven Months of 2018
NSDP/SDDS for the People's Republic of China
Market Price of Important Means of Production in Circulation, July 01-10, 2018
In the first five months of 2018, the profits made by industrial enterprises above the designated siz
Purchasing Managers Index for June 2018
Market Price of Important Means of Production in Circulation, June 21-30, 2018
In global EV battery shipments during Jan - Apr 2018, LG Chem and Samsung SDI ranked 4th and 6th
Based on Jan - Apr shipment record, Kia Motors Remain on Top 10 in Global PHEV Power Brands Ranking
Consumer Prices for May 2018
Producer Prices for the Industrial Sector for May 2018
Industrial Production Operation in May 2018
Investment in Fixed Assets for the First Five Months of 2018
National Real Estate Development and Sales in the First Five months of 2018
Producer Prices for the Industrial Sector for April 2018
Stable Performance for the National Economy in April
Total Retail Sales of Consumer Goods in April 2018
Industrial Production Operation in April 2018
National Real Estate Development and Sales in the First four months of 2018
Sales Prices of Residential Buildings in 70 Medium and Large-sized Cities in April 2018
Industrial Profits Increased in the First Four Months of 2018
Industry News
  More>>
Iron and steel sector gains strength
China’s wines take center stage
Machinery manufacturing fair boosts Sino-Russian ties
Medical device manufacturers display their latest technology
Soybean farmers store crops amid hopes of higher prices
Tourism industry opening on agenda
Tech competition eases startups' access to China market
China's excavator sales grow 44.9% in October
China's solid waste imports continue to slump on tightened ban
Delivery orders jump 25.12% to 1.35b on Singles Day
Related Links
Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast),
Global Rare Disease Diagnostics Market: Focus on Genetic Diseases, Service Providers, Competitive Landscape, and Country - Analysis and Forecast, 2018-2025
Dental Diagnostics & Surgical Equipment Market Outlook and Company Analysis - Global Forecast to 2025
Japan In Vitro Diagnostics (IVD) Market, By Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities
Flexible & Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), an
Global Transplant Diagnostics Market Analysis & Trends - Industry Forecast to 2027
Veterinary Diagnostics Market by Product (Instruments, Consumables),Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostics, Hematology, Molecular Diagnostics), Animal, End User - Global Forec
LIQUID BIOPSY MARKETS by Cancer Type by Diagnosis, Monitoring & Recurrence Testing. 2019-2023 w. Historical Data Including Screening Market Potential Size with Executive and Consultant Guides
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
Global Animal Health Diagnostics Market 2018-2022

Sitemap       |       Join Us      |       Customer Service       |       About Sino-report
Copyright © 2011-2025 Sino-report Consult Inc.
Sino-report@hotmail.com    Postmaster@sino-report.com
No.18 Zhichun Road, Haidian District. Beijing 100089.China
Information and data contained in this site is for reference only pursuant to operate your own risk
Sino-report